| Ansari M, Krajinovic M
Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation? [Editorial, Research Support, Non-U.S. Gov't]
Pharmacogenomics 2009 Nov; 10(11):1729-32.
Full Citation | Find Related Articles |
| Suttorp M, Claviez A, Bader P, et al.
Allogeneic Stem Cell Transplantation for Pediatric and Adolescent Patients with CML: Results from the Prospective Trial CML-paed I. [JOURNAL ARTICLE]
Klin Padiatr 2009 Nov; 221(6):351-357.
Abstract | Full Citation | Find Related Articles |
| Zhang W, Xia XY, Ding H, et al.
[Establishment of recipient mouse model of stem cell transplantation into testicular seminiferous tubules and improvement of transplantation techniques] [English Abstract, Journal Article]
Zhonghua Nan Ke Xue 2009 Aug; 15(8):703-7.
Abstract | Full Citation |
| Kitko CL, Levine JE, Matthews DC, et al.
Successful unrelated donor cord blood transplantation for Glanzmann's thrombasthenia. [JOURNAL ARTICLE]
Pediatr Transplant 2009 Oct 22.
Abstract | Full Citation | Find Related Articles |
| Ulrickson M, Aldridge J, Kim HT, et al.
Busulfan and cyclophosphamide (bu/cy) as a preparative regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma: a single-institution experience. [Journal Article]
Biol Blood Marrow Transplant 2009 Nov; 15(11):1447-54.
Abstract | Full Citation |
| Barba P, Piñana JL, Valcárcel D, et al.
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. [Journal Article]
Biol Blood Marrow Transplant 2009 Nov; 15(11):1439-46.
Abstract | Full Citation | Find Related Articles |
| Hamadani M, Blum W, Phillips G, et al.
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies. [Journal Article]
Biol Blood Marrow Transplant 2009 Nov; 15(11):1422-30.
Abstract | Full Citation |
| Dean RM, Pohlman B, Sweetenham JW, et al.
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 11.
Abstract | Full Citation | Find Related Articles |
| Pant S, Hamadani M, Dodds AJ, et al.
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 11.
Abstract | Full Citation | Find Related Articles |
| van Besien K, Dew A, Lin S, et al.
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Oct 3.
Abstract | Full Citation | Find Related Articles |
  |
